Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Isabel Leite

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Multiple Sclerosis and Related Disorders|November 4, 2017
Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalenceJyh Yung Hor, Thien Thien Lim, Yuen Kang Chia, et al.
Med (New York, N.Y.)|February 7, 2026
Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravisKatherine C Dodd, Kirsten Baillie, James K L Holt, et al.
Journal of Neuroimmunology|May 2, 2021
High incidence of NMDAR encephalitis among Austronesians: A population-based study in Sabah, MalaysiaChee Keong Wong, Jyh Yung Hor, Yin Pin Loo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2017
Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodiesBethan Lang, Mateusz Makuch, Teresa Moloney, et al.
Brain : a Journal of Neurology|May 12, 2012
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and JapanJoanna Kitley, M Isabel Leite, Ichiro Nakashima, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 31, 2015
MOG cell-based assay detects non-MS patients with inflammatory neurologic diseasePatrick Waters, Mark Woodhall, Kevin C O'Connor, et al.
Brain : a Journal of Neurology|November 15, 2017
Clinical presentation and prognosis in MOG-antibody disease: a UK studyMaciej Jurynczyk, Silvia Messina, Mark R Woodhall, et al.
Annals of the New York Academy of Sciences|January 30, 2018
Serological and experimental studies in different forms of myasthenia gravisAngela Vincent, Saif Huda, Michelangelo Cao, et al.
Multiple Sclerosis and Related Disorders|December 17, 2018
Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesionsMaureen A Mealy, Sarah E Mossburg, Su-Hyun Kim, et al.
Brain : a Journal of Neurology|June 22, 2014
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomesAlexander Carvajal-González, M Isabel Leite, Patrick Waters, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Multiple Sclerosis and Related Disorders|November 4, 2017
Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalenceJyh Yung Hor, Thien Thien Lim, Yuen Kang Chia, et al.
Med (New York, N.Y.)|February 7, 2026
Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravisKatherine C Dodd, Kirsten Baillie, James K L Holt, et al.
Journal of Neuroimmunology|May 2, 2021
High incidence of NMDAR encephalitis among Austronesians: A population-based study in Sabah, MalaysiaChee Keong Wong, Jyh Yung Hor, Yin Pin Loo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2017
Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodiesBethan Lang, Mateusz Makuch, Teresa Moloney, et al.
Brain : a Journal of Neurology|May 12, 2012
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and JapanJoanna Kitley, M Isabel Leite, Ichiro Nakashima, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 31, 2015
MOG cell-based assay detects non-MS patients with inflammatory neurologic diseasePatrick Waters, Mark Woodhall, Kevin C O'Connor, et al.
Brain : a Journal of Neurology|November 15, 2017
Clinical presentation and prognosis in MOG-antibody disease: a UK studyMaciej Jurynczyk, Silvia Messina, Mark R Woodhall, et al.
Annals of the New York Academy of Sciences|January 30, 2018
Serological and experimental studies in different forms of myasthenia gravisAngela Vincent, Saif Huda, Michelangelo Cao, et al.
Multiple Sclerosis and Related Disorders|December 17, 2018
Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesionsMaureen A Mealy, Sarah E Mossburg, Su-Hyun Kim, et al.
Brain : a Journal of Neurology|June 22, 2014
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomesAlexander Carvajal-González, M Isabel Leite, Patrick Waters, et al.
Pageof 8